Literature DB >> 2839237

Different metabolic behavior of long-chain n-3 polyunsaturated fatty acids in human platelets.

M Croset1, M Guichardant, M Lagarde.   

Abstract

Whereas numerous studies deal with the effects and metabolism of eicosapentaenoic acid (20:5(n - 3)) in platelets, very few concern docosahexaenoic acid (22:6(n - 3)), although both acids are consumed in equal amounts from most fish fat. The present paper reports the modulation of 22:6(n - 3) oxygenation as well as that of endogenous arachidonic acid (20:4(n - 6)) in 22:6(n - 3)-rich platelets. Like the oxygenation of 20:5(n - 3), the lipoxygenation of 22:6(n - 3) occurred at a low level when incubated alone, but was markedly increased in the presence of 20:4(n - 6), suggesting a similar peroxide tone dependency. 20:5(n - 3) could not replace 20:4(n - 6) in the increasing 22:6(n - 3) lipoxygenation, whereas 22:6(n - 3) shared the potentiating effect of 20:4(n - 6) on both the cyclooxygenation and the lipoxygenation of 20:5(n - 3). On the other hand, 20:5(n - 3), 22:6(n - 3) or 20:5(n - 3) + 22:6(n - 3) enrichment of platelet phospholipids inhibited the formation of cyclooxygenase but not lipoxygenase products from endogenous 20:4(n - 6) in thrombin-stimulated platelets. In doing so, 22:6(n - 3) appeared even more potent than 20:5(n - 3), although it was not liberated after acylation in phospholipids, the opposite of what was observed with 20:5(n - 3). Therefore, it seems that, in contrast to 20:5(n - 3), which may compete with endogenous 20:4(n - 6) at the cyclooxygenase level, 22:6(n - 3) would affect the latter enzyme activity in a different way. We conclude that 20:5(n - 3) and 22:6(n - 3) behave differently and might act synergistically on the inhibition of platelet functions after fish fat intake.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839237     DOI: 10.1016/0005-2760(88)90121-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Metabolic interactions between eicosanoids in blood and vascular cells.

Authors:  M Lagarde; N Gualde; M Rigaud
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

2.  The effect of a fish oil diet on the fatty acid composition of individual phospholipids and eicosanoid production by rat platelets.

Authors:  M Careaga-Houck; H Sprecher
Journal:  Lipids       Date:  1989-06       Impact factor: 1.880

3.  Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity.

Authors:  D C Gaudette; B J Holub
Journal:  Lipids       Date:  1990-03       Impact factor: 1.880

4.  Inhibitory effect of stearidonic acid (18:4 n-3) on platelet aggregation and arachidonate oxygenation.

Authors:  V Kockmann; D Spielmann; H Traitler; M Lagarde
Journal:  Lipids       Date:  1989-12       Impact factor: 1.880

5.  EPA, but not DHA, decreases mean platelet volume in normal subjects.

Authors:  Yongsoon Park; William Harris
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

6.  [In vitro studies of the effect of different mixture proportions of omega-3 and omega-6 fatty acids on thrombocyte aggregation and thromboxane synthesis in human thrombocytes].

Authors:  S Stroh; I Elmadfa
Journal:  Z Ernahrungswiss       Date:  1991-09

7.  Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro.

Authors:  M Croset; Y Bayon; M Lagarde
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

8.  A unique pool of free arachidonate serves as substrate for both cyclooxygenase and lipoxygenase in platelets.

Authors:  F Chevy; C Wolf; O Colard
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.